Current Ratio of Jasper Therapeutics, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Jasper Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Jasper Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 328%, a 65% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Jasper Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 328% -614% -65% 30 Sep 2025
Q2 2025 441% -537% -55% 30 Jun 2025
Q1 2025 664% -363% -35% 31 Mar 2025
Q4 2024 856% -226% -21% 31 Dec 2024
Q3 2024 942% -169% -15% 30 Sep 2024
Q2 2024 978% -123% -11% 30 Jun 2024
Q1 2024 1027% +27% +2.7% 31 Mar 2024
Q4 2023 1082% +228% +27% 31 Dec 2023
Q3 2023 1111% +121% +12% 30 Sep 2023
Q2 2023 1101% +2% +0.15% 30 Jun 2023
Q1 2023 1000% -127% -11% 31 Mar 2023
Q4 2022 854% -228% -21% 31 Dec 2022
Q3 2022 989% +81% +8.9% 30 Sep 2022
Q2 2022 1100% +614% +126% 30 Jun 2022
Q1 2022 1126% +617% +121% 31 Mar 2022
Q4 2021 1082% +558% +106% 31 Dec 2021
Q3 2021 908% +205% +29% 30 Sep 2021
Q2 2021 486% 30 Jun 2021
Q1 2021 509% 31 Mar 2021
Q4 2020 524% 31 Dec 2020
Q3 2020 704% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.